Electrophoretic Mobility Shift Assay
"Electrophoretic Mobility Shift Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An electrophoretic technique for assaying the binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. If the labeled compound is bound by the other compound, then the mobility of the labeled compound through the electrophoretic medium will be retarded.
| Descriptor ID |
D024202
|
| MeSH Number(s) |
E05.196.401.500
|
| Concept/Terms |
Electrophoretic Mobility Shift Assay- Electrophoretic Mobility Shift Assay
- EMSA Electrophoretic Technique
- EMSA Electrophoretic Techniques
- Electrophoretic Technique, EMSA
- Electrophoretic Techniques, EMSA
- Technique, EMSA Electrophoretic
- Techniques, EMSA Electrophoretic
- Band Shift Mobility Assay
- Mobility Shift Assay
- Assay, Mobility Shift
- Assays, Mobility Shift
- Mobility Shift Assays
- Bandshift Mobility Assay
- Assay, Bandshift Mobility
- Assays, Bandshift Mobility
- Bandshift Mobility Assays
- Mobility Assay, Bandshift
- Mobility Assays, Bandshift
Supershift Mobility Assay- Supershift Mobility Assay
- Assay, Supershift Mobility
- Assays, Supershift Mobility
- Mobility Assay, Supershift
- Mobility Assays, Supershift
- Supershift Mobility Assays
Gel Shift Analysis- Gel Shift Analysis
- Analyses, Gel Shift
- Analysis, Gel Shift
- Gel Shift Analyses
- Gelshift Analysis
- Gel Retardation Assay
- Assay, Gel Retardation
- Assays, Gel Retardation
- Gel Retardation Assays
|
Below are MeSH descriptors whose meaning is more general than "Electrophoretic Mobility Shift Assay".
Below are MeSH descriptors whose meaning is more specific than "Electrophoretic Mobility Shift Assay".
This graph shows the total number of publications written about "Electrophoretic Mobility Shift Assay" by people in this website by year, and whether "Electrophoretic Mobility Shift Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 4 | 4 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Electrophoretic Mobility Shift Assay" by people in Profiles.
-
Brown SZ, Agostini LC, Thomsett HL, Brody JR. Ultra-fast conductive media for RNA electrophoretic mobility shift assays. Biotechniques. 2020 02; 68(2):101-105.
-
Jain A, Brown SZ, Thomsett HL, Londin E, Brody JR. Evaluation of Post-transcriptional Gene Regulation in Pancreatic Cancer Cells: Studying RNA Binding Proteins and Their mRNA Targets. Methods Mol Biol. 2019; 1882:239-252.
-
Kong X, Simon LM, Holinstat M, Shaw CA, Bray PF, Edelstein LC. Identification of a functional genetic variant driving racially dimorphic platelet gene expression of the thrombin receptor regulator, PCTP. Thromb Haemost. 2017 05 03; 117(5):962-970.
-
Chandramouly G, McDevitt S, Sullivan K, Kent T, Luz A, Glickman JF, Andrake M, Skorski T, Pomerantz RT. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers. Chem Biol. 2015 Nov 19; 22(11):1491-1504.
-
Goodson KA, Wang Z, Haeusler AR, Kahn JD, English DS. LacI-DNA-IPTG loops: equilibria among conformations by single-molecule FRET. J Phys Chem B. 2013 Apr 25; 117(16):4713-22.
-
Rao S, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu Z, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang R, Balachandran S, Zambetti GP, Testa JR, Look AT, Wiest DL. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 2012 Nov 01; 120(18):3764-73.
-
Pierrat MJ, Marsaud V, Mauviel A, Javelaud D. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-?. J Biol Chem. 2012 May 25; 287(22):17996-8004.
-
Tripathi SK, Yadav S, Gupta KC, Kumar P. Synthesis and evaluation of N-(2,3-dihydroxypropyl)-PEIs as efficient vectors for nucleic acids. Mol Biosyst. 2012 Apr; 8(5):1426-34.
-
Doyle GA, Wang MJ, Chou AD, Oleynick JU, Arnold SE, Buono RJ, Ferraro TN, Berrettini WH. In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. PLoS One. 2011; 6(8):e23373.
-
Palomer X, ?lvarez-Guardia D, Davidson MM, Chan TO, Feldman AM, V?zquez-Carrera M. The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells. PLoS One. 2011; 6(5):e19724.